July 19, 2023 03:24 PM EDT
Pharma
Marketing

Tik­Tok takes down ac­counts for weight loss in­flu­encers who dis­cussed We­govy, Moun­jaro

Beth Snyder Bulik

Senior Editor

Some weight loss in­flu­encers on Tik­Tok have been banned af­ter talk­ing about GLP-1 med­ica­tions in­clud­ing No­vo Nordisk’s We­govy and Ozem­pic and Eli Lil­ly’s Moun­jaro. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times